hpv
-
Genera Biosystems Receives Approval in Australia for HPV Test Kit
The Australian Therapeutic Goods Administration (TGA) has approved the entry of Genera Biosystems’ PapType Human Papillomavirus (HPV) test kit onto the Australian Register of Therapeutic Goods (ARTG). The company is now permitted to supply the test…
hpv | 27 January 2010
-
Genera Biosystems Releases Results on HPV Detection Assay
Genera Biosystems has released the results of a major clinical study on its PapType Human Papillomavirus (HPV) detection assay, carried out in conjunction with the Royal Women’s Hospital (RWH), Melbourne, Australia. The RWH is a World Health Organi…
hpv | 09 September 2009
-
Health Leaders Convene in Korea to Save Women’s Lives
The International Vaccine Institute (IVI) has convened a symposium of 150 experts, policymakers, and decision makers from more than 36 countries from the Asia-Pacific and Middle East regions. This is to develop solutions to expand vaccination program…
hpv | 11 June 2009
-
HPV Testing Reduces Deaths from Cervical Cancer
Results from an eight-year trial involving more than 130,000 women has been published. It demonstrates that in low-resource settings a single round of Human Papilloma Virus (HPV) testing significantly reduces the numbers of advanced cervical cancers …
hpv | 10 April 2009
-
Qiagen Reports Strong Growth in HPV Testing
Qiagen N.V. has reported that its consolidated net sales for the third quarter of 2008 increased 31% to $230.8 million from $176.6 million for the same quarter in 2007. In the three-month period ended September 30 this year, the company reported o…
hpv | 01 November 2008
-
MSD India launches country’s first HPV vaccine
MSD Pharmaceuticals (India), the local affiliate of Merck has announced the launch of Gardasil [Quadrivalent Human Papillomavirus (Types 6, 11, 16 & 18) Vaccine], India’s first vaccine to help prevent cervical cancer caused by the HPV types contain…
hpv | 17 October 2008
-
Predicting cervical disease developing countries
A new HPV test developed by Qiagen specifically for use in regions of the world with scarce resources is “substantially†more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in thes…
hpv | 24 September 2008
